We have limited Portuguese content available. View Portuguese content.


India Private Equity Report 2021

India Private Equity Report 2021

Despite the pandemic, India’s Private Equity industry sustained its momentum.

  • min read


India Private Equity Report 2021

2020 was a momentous year, with Covid-19 upending some forecasts and trends whilst reinforcing and accelerating others. The economic impact of the coronavirus pandemic in India has been significant, causing GDP contraction of more than 10% and leading to the highest-ever annual fiscal deficit at 9.5% for fiscal year 2021. Imposition of a nationwide lockdown in late March 2020 halted over 65% of the Indian economy and led to the loss of more than 4 million jobs in the formal sector.

  • Written in collaboration with IVCA

However, things have turned a corner in 2021, with unprecedented stock market gains on the back of sooner-than-expected business recovery, strong foreign institutional investor (FII) inflows, and Covid-19 vaccine approval and administration. The latest forecasts by the IMF expect strong rebound in 2021, with growth returning to the long-term trend of 7%–8% from 2022 to 2025.

Despite Covid-19, we have seen a few investment themes continue from prior years. Strong deal volume flow continued with a 5% year-over-year (YOY) increase despite a slowdown in the total value of investments (excluding Jio Platforms and Reliance Retail deals). Growth equity momentum was sustained with $10 billion in investments, more than in all previous years and nearly at par with 2019. From a sector standpoint, strong momentum continued in consumer tech and IT/IT-enabled services (ITES). Additionally, India-focused dry powder remained resilient at $8 billion, with the share of oversubscribed and at-target funds increasing further.

At the same time, new themes emerged in 2020. There was a moderation in cheque sizes as average deal size declined by 25% compared with 2019. In terms of sector activity, healthcare witnessed a surge with big-ticket deals in pharmaceuticals manufacturing and distribution and active pharmaceutical ingredient (API) development. However, banking, financial services, and insurance (BFSI) investment value fell by 60% due to uncertainty over nonperforming assets (NPAs), the Reserve Bank of India (RBI)-imposed bank moratorium, and the impact of Covid-19 on lending. From an exit perspective, multiples rose by 1.4 times even as exit value dipped by 30% in 2020 vs. 2019.

In 2020, the Indian Private Equity (PE) Landscape witnessed strong investment momentum with $62 billion in deal value and 40% from Jio Platforms and Reliance Retail deals. Investment activity was muted from March to May due to Covid-19-led uncertainty, but it recovered strongly in H2 to pre–Covid-19 levels with late-stage and buyout deals witnessing increased traction. The pandemic also led to a shift in the type of deals made, with investors focusing on alternate investment strategies such as distressed opportunistic sales and qualified institutional placements (QIPs).


Quer saber mais?

Ajudamos líderes do mundo todo a lidar com desafios e oportunidades cruciais para suas organizações. Juntos, criamos mudanças e resultados duradouros.